Award

(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

30 Sep 2022 at 08:23

Award Notice
Summary of the contracting process

Newcastle University has awarded a £30,000 contract to Cambridge Drug Discovery for the provision of business consultancy services. The contract period is from 26th September 2022 to 30th June 2023. The tender, titled "(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research," falls under the business and management consultancy services category. The procurement method used was a selective procedure, with a tender period ending on 19th August 2022. The contract is aimed at initiating phases to review targets, secure seed finance, and draft funding proposals for preclinical studies.

This procurement opportunity can benefit small and medium-sized enterprises (SMEs) in the business consultancy sector. Businesses well-suited to compete are those with expertise in commercialization of research, drug discovery, and investment pitching. The contract presents a chance for growth by collaborating with Newcastle University and contributing to advancing cancer and neurodegenerative disease research. Companies with capabilities in navigating approval processes, securing funding, and developing business plans are encouraged to participate in this exciting opportunity.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Notice Description

Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related TFs, (ATF4 CREB, and ID1) which are implicated in a range of cancer types that include glioma, breast cancer, acute myeloid leukaemia, and the aggregation of a-synuclein and amyloid implicated in Parkinson's Disease and Alzheimer's disease respectively. The initial brief of the executive will be to: Phase (1) September 2022 - December 2022 - Work with Jody Mason and Uni TT team to review current targets, oversee screening programme and lead candidates and produce a viable 5-year business plan and associated pitch deck; Phase (2)September 2022 - December 2022 - Navigate University approval process, work with TT team to get approval from the University Commercialisation Executive Board Phase (3) January 2023-March 2023 - a. Act for the company in the spin out legal process and review the Articles of Association, Shareholder's agreement and IP licence put together by the University; b. Work with the Unit TT team to obtain founder academics' and University approval for appointment as CEO. c. Provide to the University of Bath all matters necessary for Research England reporting requirements. Phase (4) January 2023-June 2023 - Pitch to investors alongside Jody Mason, secure seed finance, draft and submit Innovate UK proposal for preclinical funding Phase (5) The outcome of Phase 4 will provide seed finance and IUK funding for preclinical studies, which will be sufficient to employ the executive and drive preclinical development. The appointment of the executive as CEO will be at the discretion of the board and the University of Bath and will be subject to confirmation, typically at Stage 4 above.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-869fb8d3-6d95-4480-bf4b-076d7c23afe4
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c2dc1e8e-eba7-40c1-9eaf-71a6046956f5
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Restricted procedure
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
£30,000 Under £100K
Lots Value
Not specified
Awards Value
£30,000 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
30 Sep 20223 years ago
Submission Deadline
19 Aug 2022Expired
Future Notice Date
Not specified
Award Date
20 Sep 20223 years ago
Contract Period
25 Sep 2022 - 30 Jun 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
Not specified
Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

CAMBRIDGE DRUG DISCOVERY

Further Information

Notice Documents

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-869fb8d3-6d95-4480-bf4b-076d7c23afe4-2022-09-30T09:23:47+01:00",
    "date": "2022-09-30T09:23:47+01:00",
    "ocid": "ocds-b5fd17-869fb8d3-6d95-4480-bf4b-076d7c23afe4",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "NCL001-DN621813-23144958",
        "title": "(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.",
        "description": "Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related TFs, (ATF4 CREB, and ID1) which are implicated in a range of cancer types that include glioma, breast cancer, acute myeloid leukaemia, and the aggregation of a-synuclein and amyloid implicated in Parkinson's Disease and Alzheimer's disease respectively. The initial brief of the executive will be to: Phase (1) September 2022 - December 2022 - Work with Jody Mason and Uni TT team to review current targets, oversee screening programme and lead candidates and produce a viable 5-year business plan and associated pitch deck; Phase (2)September 2022 - December 2022 - Navigate University approval process, work with TT team to get approval from the University Commercialisation Executive Board Phase (3) January 2023-March 2023 - a. Act for the company in the spin out legal process and review the Articles of Association, Shareholder's agreement and IP licence put together by the University; b. Work with the Unit TT team to obtain founder academics' and University approval for appointment as CEO. c. Provide to the University of Bath all matters necessary for Research England reporting requirements. Phase (4) January 2023-June 2023 - Pitch to investors alongside Jody Mason, secure seed finance, draft and submit Innovate UK proposal for preclinical funding Phase (5) The outcome of Phase 4 will provide seed finance and IUK funding for preclinical studies, which will be sufficient to employ the executive and drive preclinical development. The appointment of the executive as CEO will be at the discretion of the board and the University of Bath and will be subject to confirmation, typically at Stage 4 above.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 30000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Restricted procedure",
        "tenderPeriod": {
            "endDate": "2022-08-19T12:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2022-09-18T00:00:00+01:00",
            "endDate": "2023-06-30T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-59869",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Natalie Morton",
                "email": "natalie.morton@ncl.ac.uk",
                "telephone": "+44 1912086396"
            },
            "details": {
                "url": "https://www.ncl.ac.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-220770",
            "name": "Cambridge Drug Discovery",
            "identifier": {
                "legalName": "Cambridge Drug Discovery"
            },
            "address": {
                "streetAddress": "35 Tunwells Lane Great Shelford Cambridge Cambridgeshire United Kingdom CB22 5LJ"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-59869",
        "name": "Newcastle University"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-869fb8d3-6d95-4480-bf4b-076d7c23afe4-1",
            "status": "active",
            "date": "2022-09-21T00:00:00+01:00",
            "datePublished": "2022-09-30T09:23:47+01:00",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-220770",
                    "name": "Cambridge Drug Discovery"
                }
            ],
            "contractPeriod": {
                "startDate": "2022-09-26T00:00:00+01:00",
                "endDate": "2023-06-30T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/c2dc1e8e-eba7-40c1-9eaf-71a6046956f5",
                    "datePublished": "2022-09-30T09:23:47+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}